215 related articles for article (PubMed ID: 33269017)
1. Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis.
Ćulafić M; Vezmar-Kovačević S; Dopsaj V; Oluić B; Bidžić N; Miljković B; Ćulafić Đ
J Med Biochem; 2020 Sep; 39(3):290-298. PubMed ID: 33269017
[TBL] [Abstract][Full Text] [Related]
2. A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.
Sharma BC; Kumar A; Garg V; Reddy RS; Sakhuja P; Sarin SK
J Clin Exp Hepatol; 2012 Dec; 2(4):333-7. PubMed ID: 25755455
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh.
Alam S; Noor-E-Alam SM; Chowdhury ZR; Alam M; Kabir J
World J Hepatol; 2013 May; 5(5):281-7. PubMed ID: 23717739
[TBL] [Abstract][Full Text] [Related]
4. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis.
Satapathy SK; Garg S; Chauhan R; Sakhuja P; Malhotra V; Sharma BC; Sarin SK
Am J Gastroenterol; 2004 Oct; 99(10):1946-52. PubMed ID: 15447754
[TBL] [Abstract][Full Text] [Related]
6. Metformin in nonalcoholic steatohepatitis: a randomized controlled trial.
Kazemi R; Aduli M; Sotoudeh M; Malekzadeh R; Seddighi N; Sepanlou SG; Merat S
Middle East J Dig Dis; 2012 Jan; 4(1):16-22. PubMed ID: 24829630
[TBL] [Abstract][Full Text] [Related]
7. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
Adams LA; Zein CO; Angulo P; Lindor KD
Am J Gastroenterol; 2004 Dec; 99(12):2365-8. PubMed ID: 15571584
[TBL] [Abstract][Full Text] [Related]
8. A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests.
Culafic M; Vezmar Kovacevic S; Dopsaj V; Stulic M; Vlaisavljevic Z; Miljkovic B; Culafic D
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163711
[No Abstract] [Full Text] [Related]
9. Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial.
Shavakhi A; Minakari M; Firouzian H; Assali R; Hekmatdoost A; Ferns G
Int J Prev Med; 2013 May; 4(5):531-7. PubMed ID: 23930163
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
Shyangdan D; Clar C; Ghouri N; Henderson R; Gurung T; Preiss D; Sattar N; Fraser A; Waugh N
Health Technol Assess; 2011 Nov; 15(38):1-110. PubMed ID: 22059955
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.
Zein CO; Yerian LM; Gogate P; Lopez R; Kirwan JP; Feldstein AE; McCullough AJ
Hepatology; 2011 Nov; 54(5):1610-9. PubMed ID: 21748765
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients.
Yakaryilmaz F; Guliter S; Ozenirler S; Erdem O; Akyol G
Curr Ther Res Clin Exp; 2004 May; 65(3):266-77. PubMed ID: 24672082
[TBL] [Abstract][Full Text] [Related]
13. Effects of pentoxifylline on nonalcoholic fatty liver disease: a meta-analysis.
Du J; Ma YY; Yu CH; Li YM
World J Gastroenterol; 2014 Jan; 20(2):569-77. PubMed ID: 24574727
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial.
Van Wagner LB; Koppe SW; Brunt EM; Gottstein J; Gardikiotes K; Green RM; Rinella ME
Ann Hepatol; 2011; 10(3):277-86. PubMed ID: 21677329
[TBL] [Abstract][Full Text] [Related]
15. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
16. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
17. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
Gonciarz M; Gonciarz Z; Bielanski W; Mularczyk A; Konturek PC; Brzozowski T; Konturek SJ
J Physiol Pharmacol; 2010 Dec; 61(6):705-10. PubMed ID: 21224501
[TBL] [Abstract][Full Text] [Related]
18. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
Nagaya T; Tanaka N; Kimura T; Kitabatake H; Fujimori N; Komatsu M; Horiuchi A; Yamaura T; Umemura T; Sano K; Gonzalez FJ; Aoyama T; Tanaka E
BBA Clin; 2015 Jun; 3():168-74. PubMed ID: 26674248
[TBL] [Abstract][Full Text] [Related]
20. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis.
Patton HM; Lavine JE; Van Natta ML; Schwimmer JB; Kleiner D; Molleston J;
Gastroenterology; 2008 Dec; 135(6):1961-1971.e2. PubMed ID: 19013463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
